Canonical WNT signalling determines lineage specificity in Wilms tumour
- PMID: 19137020
- DOI: 10.1038/onc.2008.455
Canonical WNT signalling determines lineage specificity in Wilms tumour
Abstract
Wilms tumours (WTs) have two distinct types of histology with or without ectopic mesenchymal elements, suggesting that WTs arise from either the mesenchymal or epithelial nephrogenic lineages. Regardless of the presence or absence of CTNNB1 mutations, nuclear accumulation of beta-catenin is often observed in WTs with ectopic mesenchymal elements. Here, we addressed the relationship between the WNT-signalling pathway and lineage in WTs by examining CTNNB1 and WT1 mutations, nuclear accumulation of beta-catenin, tumour histology and gene expression profiles. In addition, we screened for mutations in WTX, which has been proposed to be a negative regulator of the canonical WNT-signalling pathway. Unsupervised clustering analysis identified two classes of tumours: mesenchymal lineage WNT-dependent tumours, and epithelial lineage WNT-independent tumours. In contrast to the mesenchymal lineage specificity of CTNNB1 mutations, WTX mutations were surprisingly observed in both lineages. WTX-mutant WTs with ectopic mesenchymal elements had nuclear accumulation of beta-catenin, upregulation of WNT target genes and an association with CTNNB1 mutations in exon 7 or 8. However, epithelial lineage WTs with WTX mutations had no indications of active WNT signalling, suggesting that the involvement of WTX in the WNT-signalling pathway may be lineage dependent, and that WTX may have an alternative function to its role in the canonical WNT-signalling pathway.
Similar articles
-
Wilms tumour histology is determined by distinct types of precursor lesions and not epigenetic changes.J Pathol. 2008 Aug;215(4):377-87. doi: 10.1002/path.2366. J Pathol. 2008. PMID: 18484682
-
Wilms tumor cells with WT1 mutations have characteristic features of mesenchymal stem cells and express molecular markers of paraxial mesoderm.Hum Mol Genet. 2010 May 1;19(9):1651-68. doi: 10.1093/hmg/ddq042. Epub 2010 Jan 27. Hum Mol Genet. 2010. PMID: 20106868
-
WTX inactivation is a frequent, but late event in Wilms tumors without apparent clinical impact.Genes Chromosomes Cancer. 2009 Dec;48(12):1102-11. doi: 10.1002/gcc.20712. Genes Chromosomes Cancer. 2009. PMID: 19760609
-
Pathology, genetics and cytogenetics of Wilms' tumour.Pathology. 2011 Jun;43(4):302-12. doi: 10.1097/PAT.0b013e3283463575. Pathology. 2011. PMID: 21516053 Review.
-
Wnt/β-catenin signalling in adrenal physiology and tumour development.Mol Cell Endocrinol. 2012 Mar 31;351(1):87-95. doi: 10.1016/j.mce.2011.09.009. Epub 2011 Sep 10. Mol Cell Endocrinol. 2012. PMID: 21930188 Review.
Cited by
-
Pygo2 functions as a prognostic factor for glioma due to its up-regulation of H3K4me3 and promotion of MLL1/MLL2 complex recruitment.Sci Rep. 2016 Feb 23;6:22066. doi: 10.1038/srep22066. Sci Rep. 2016. PMID: 26902498 Free PMC article.
-
Stratification of Wilms tumor by genetic and epigenetic analysis.Oncotarget. 2012 Mar;3(3):327-35. doi: 10.18632/oncotarget.468. Oncotarget. 2012. PMID: 22470196 Free PMC article.
-
Analyzing the gene expression profile of anaplastic histology Wilms' tumor with real-time polymerase chain reaction arrays.Cancer Cell Int. 2015 Apr 20;15:44. doi: 10.1186/s12935-015-0197-x. eCollection 2015. Cancer Cell Int. 2015. PMID: 26136641 Free PMC article.
-
Wilms' tumours: about tumour suppressor genes, an oncogene and a chameleon gene.Nat Rev Cancer. 2011 Feb;11(2):111-21. doi: 10.1038/nrc3002. Epub 2011 Jan 20. Nat Rev Cancer. 2011. PMID: 21248786 Free PMC article. Review.
-
Genetic variation frequencies in Wilms' tumor: A meta-analysis and systematic review.Cancer Sci. 2016 May;107(5):690-9. doi: 10.1111/cas.12910. Epub 2016 Mar 18. Cancer Sci. 2016. PMID: 26892980 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous